Literature DB >> 761382

Blood cyanide and thiocyanate concentrations after administration of sodium nitroprusside as hypotensive agent in neurosurgery.

M Bogusz, J Moroz, J Karski, J Gierz, A Regieli, R Witkowska.   

Abstract

In a group of 50 neurosurgical patients receiving sodium nitroprusside as a hypotensive agent, in doses of 50--2131 microgram/kg body weight, whole blood cyanide was estimated before infusion of drug, during infusion, immediately after infusion, and 1 and 3 h later. Cyanide values increased significantly, reaching the maximum in a sample taken immediately after infusion (mean value, 333; highest value, 1800 microgram/liter). Values correlated closely with both dose and rate of infusion. Blood thiocyanate, estimated before, immediately after, and 3 h after the infusion, showed no significant changes in thiocyanate concentration. In any case, no signs or symptoms of cyanide or thiocyanate poisoning were observed. We conclude that sodium nitroprusside, in the proper dose and given at the proper rate, does not precipitate cyanide poisoning.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761382

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

Review 1.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

Review 2.  Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

Authors:  V Schulz
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

3.  Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate.

Authors:  V Schulz; R Gross; T Pasch; J Busse; G Loeschcke
Journal:  Klin Wochenschr       Date:  1982-11-15

4.  Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children.

Authors:  J G Linakis; P G Lacouture; A Woolf
Journal:  Pediatr Cardiol       Date:  1991-10       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.